Clinical Trials Sponsored by Mundipharma CVA

Total 4862 results

Mundipharma Pte Ltd.

Completed

Analgesic Treatment for Cancer Pain in South East Asia (ACE)

Pain
Mundipharma Korea Ltd

Completed

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

Rheumatoid Arthritis

Korea, Republic of
Mundipharma Research Limited

Completed

An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion

Pain

United Kingdom
Mundipharma Korea Ltd

Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (NOBLE)

Spinal Disorder

Korea, Republic of
Mundipharma Medical Company

Completed

Morphine Slow-release Capsules in Substitution Therapy

Opiate Dependent

Switzerland
Mundipharma Research Limited

Terminated

Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia

Spain
Mundipharma Research Limited

Completed

Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors

Soft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast Cancer

United States, Canada
Mundipharma Research Limited

Terminated

A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR

Polymyalgia Rheumatica

United Kingdom
Mundipharma Research Limited

Completed

Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma

Asthma, Bronchial

Hungary
Mundipharma Research Limited

Terminated

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (BUP1501)

Chemotherapy Induced Mucositis | Mouth Pain

Denmark, United Kingdom
Mundipharma Research Limited

Terminated

A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

Severe Caner Pain

United Kingdom
Mundipharma Research Limited

Completed

Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

Asthma Bronchiale

United Kingdom
Mundipharma Research Limited

Completed

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

Asthma

United Kingdom, Sweden, Australia, New Zealand, Slovakia
Mundipharma Korea Ltd

Completed

Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)

Pain

Korea, Republic of
Mundipharma Research Limited

Completed

Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution

Opioid Substitution Treatment
Mundipharma Research Limited

Completed

A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

Pain

United Kingdom
Mundipharma Korea Ltd

Completed

A Study Comparing Norspan Patch and Oral Tramadol

Osteoarthritis

Korea, Republic of
Mundipharma Research Limited

Completed

A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.

Pain

United Kingdom
Mundipharma Research Limited

Completed

Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK

Chronic Pain

United Kingdom
Mundipharma Research Limited

Completed

Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.

Brain Metastases | Solid Tumour Neoplastic Meningitis

Austria, Germany
Mundipharma Research Limited

Completed

A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

Asthma | COPD

United Kingdom
Taiwan Mundipharma Pharmaceuticals Ltd.

Completed

Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain (STOP Pain)

Pain | Cancer

Taiwan
Taiwan Mundipharma Pharmaceuticals Ltd.

Completed

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

Pain | Cancer

Taiwan
Mundipharma SAS
AXONAL; Exystat

Completed

Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma (Pen ASAP)

Pain, Acute

France
Taiwan Mundipharma Pharmaceuticals Ltd.

Unknown

Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients (GPM)

Pain | Cancer

Taiwan
Taiwan Mundipharma Pharmaceuticals Ltd.

Unknown

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Peripheral T Cell Lymphoma | Progression, Disease

Taiwan
Mundipharma Pharmaceuticals Sdn. Bhd.

Completed

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Osteoarthritis | Rheumatoid Arthritis | Lower Back Pain | Joint Pain | Muscle Pain

Malaysia
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OTR Tablet 40 mg Fasted-state Bioequivalence Study

Chronic Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study

Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain

Cancer Pain

China
Mundipharma Research GmbH & Co KG

Completed

Oxycodone-naloxone in Relieving Opioid-related Constipation

Pain
Mundipharma Research GmbH & Co KG

Completed

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Pain | Cancer | Constipation

United Kingdom
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Cancer
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

Other Acute Postoperative Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Norspan Transdermal Patches Study in Osteoarthritis Patients

Osteoarthritis Disorders

China
Mundipharma Research GmbH & Co KG

Completed

A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

Parkinson's Disease With Severe Pain

United Kingdom, Spain, Germany, Hungary, Czech Republic, Poland, Romania
Mundipharma Research GmbH & Co KG

Completed

A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy

Moderate to Severe Pain Due to Diabetic Polyneuropathy

Germany
Norpharma A/S
Mundipharma Finland

Completed

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine

Pain | Osteoarthritis

Finland
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OTR Tablet 40 mg Fed-state Bioequivalence Study

Chronic Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Pain | Cancer

China
Mundipharma Research GmbH & Co KG

Completed

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Mundipharma Research GmbH & Co KG

Completed

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

Chronic Osteoarthritis

Spain, Belgium, Finland, Czechia, Germany, Hungary
Mundipharma Research GmbH & Co KG

Completed

Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib). (STARDOM1)

Acute Pain

Germany, Italy, Canada, Hungary, Poland, Spain
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OxyNorm Capsules in Post-Operative Pain Study

Postoperative Pain
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

Herpes Zoster Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OTR Tablet 10 mg Fasted-state Bioequivalence Study

Chronic Pain

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL

Refractory Peripheral T-Cell Lymphoma | Relapsed T-Cell Lymphoma

China
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients

Chronic Pain

China

3

Subscribe